[Clinical efficacy of ketoprofen in rheumatology]. 1978

G Lotti, and P Greco, and U Lanzara, and N Imbimbo

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G Lotti, and P Greco, and U Lanzara, and N Imbimbo
January 1976, Rheumatology and rehabilitation,
G Lotti, and P Greco, and U Lanzara, and N Imbimbo
January 1976, Rheumatology and rehabilitation,
G Lotti, and P Greco, and U Lanzara, and N Imbimbo
October 1983, Canadian Medical Association journal,
G Lotti, and P Greco, and U Lanzara, and N Imbimbo
September 2020, Internal medicine journal,
G Lotti, and P Greco, and U Lanzara, and N Imbimbo
June 2002, Neurology,
G Lotti, and P Greco, and U Lanzara, and N Imbimbo
February 1998, Journal of clinical pharmacology,
G Lotti, and P Greco, and U Lanzara, and N Imbimbo
July 1992, La Clinica terapeutica,
G Lotti, and P Greco, and U Lanzara, and N Imbimbo
October 2010, Paediatric drugs,
G Lotti, and P Greco, and U Lanzara, and N Imbimbo
December 1988, Journal of clinical pharmacology,
G Lotti, and P Greco, and U Lanzara, and N Imbimbo
January 1979, Reumatologia,
Copied contents to your clipboard!